A PHASE III, OPEN-LABEL, MULTICENTER, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF GLOFITAMAB IN COMBINATION WITH GEMCITABINE

Administered By

Awarded By

Contributors

Start/End

  • December 8, 2021 - December 30, 2026